|
1
|
Fuster V, Rydén LE, Cannom DS, Crijns HJ,
Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe
JE, et al: American College of Cardiology Foundation/American Heart
Association Task Force: 2011 ACCF/AHA/HRS focused updates
incorporated into the ACC/AHA/ESC 2006 guidelines for the
management of patients with atrial fibrillation: a report of the
American College of Cardiology Foundation/American Heart
Association Task Force on practice guidelines. Circulation.
123:e269–e367. 2011.
|
|
2
|
Go AS, Hylek EM, Phillips KA, Chang Y,
Henault LE, Selby JV and Singer DE: Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management
and stroke prevention: the AnTicoagulation and Risk Factors in
Atrial Fibrillation (ATRIA) Study. JAMA. 285:2370–2375. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lloyd-Jones DM, Wang TJ, Leip EP, Larson
MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA
and Benjamin EJ: Lifetime risk for development of atrial
fibrillation: the Framingham Heart Study. Circulation.
110:1042–1046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolf PA, Abbott RD and Kannel WB: Atrial
fibrillation as an independent risk factor for stroke: the
Framingham Study. Stroke. 22:983–988. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benjamin EJ, Wolf PA, D’Agostino RB,
Silbershatz H, Kannel WB and Levy D: Impact of atrial fibrillation
on the risk of death: the Framingham Heart Study. Circulation.
98:946–952. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Magnani JW, Rienstra M, Lin H, Sinner MF,
Lubitz SA, McManus DD, Dupuis J, Ellinor PT and Benjamin EJ: Atrial
fibrillation: current knowledge and future directions in
epidemiology and genomics. Circulation. 124:1982–1993. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Darbar D, Herron KJ, Ballew JD, Jahangir
A, Gersh BJ, Shen WK, Hammill SC, Packer DL and Olson TM: Familial
atrial fibrillation is a genetically heterogeneous disorder. J Am
Coll Cardiol. 41:2185–2192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ellinor PT, Yoerger DM, Ruskin JN and
MacRae CA: Familial aggregation in lone atrial fibrillation. Hum
Genet. 118:179–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arnar DO, Thorvaldsson S, Manolio TA,
Thorgeirsson G, Kristjansson K, Hakonarson H and Stefansson K:
Familial aggregation of atrial fibrillation in Iceland. Eur Heart
J. 27:708–712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Junttila MJ, Raatikainen MJ, Perkiömäki
JS, Hong K, Brugada R and Huikuri HV: Familial clustering of lone
atrial fibrillation in patients with saddleback-type ST-segment
elevation in right precordial leads. Eur Heart J. 28:463–468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Christophersen IE, Ravn LS,
Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen JH and
Christensen K: Familial aggregation of atrial fibrillation: a study
in Danish twins. Circ Arrhythm Electrophysiol. 2:378–383. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Fang WY and Liu X: Familial aggregation of lone atrial
fibrillation in the Chinese population. Intern Med. 49:2385–2391.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lubitz SA, Yin X, Fontes JD, Magnani JW,
Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D, et
al: Association between familial atrial fibrillation and risk of
new-onset atrial fibrillation. JAMA. 304:2263–2269. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fox CS, Parise H, D’Agostino RB Sr,
Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA and Benjamin EJ:
Parental atrial fibrillation as a risk factor for atrial
fibrillation in offspring. JAMA. 291:2851–2855. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brugada R, Tapscott T, Czernuszewicz GZ,
Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A,
Bachinski LL and Roberts R: Identification of a genetic locus for
familial atrial fibrillation. N Engl J Med. 336:905–911. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ellinor PT, Shin JT, Moore RK, Yoerger DM
and MacRae CA: Locus for atrial fibrillation maps to chromosome
6q14–16. Circulation. 107:2880–2883. 2003.PubMed/NCBI
|
|
17
|
Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang
Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, et al: KCNQ1
gain-of-function mutation in familial atrial fibrillation. Science.
299:251–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oberti C, Wang L, Li L, Dong J, Rao S, Du
W and Wang Q: Genome-wide linkage scan identifies a novel genetic
locus on chromosome 5p13 for neonatal atrial fibrillation
associated with sudden death and variable cardiomyopathy.
Circulation. 110:3753–3759. 2004. View Article : Google Scholar
|
|
19
|
Zhang X, Chen S, Yoo S, Chakrabarti S,
Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, et al: Mutation in
nuclear pore component NUP155 leads to atrial fibrillation and
early sudden cardiac death. Cell. 135:1017–1027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Volders PG, Zhu Q, Timmermans C, Eurlings
PM, Su X, Arens YH, Li L, Jongbloed RJ, Xia M, Rodriguez LM and
Chen YH: Mapping a novel locus for familial atrial fibrillation on
chromosome 10p11–q21. Heart Rhythm. 4:469–475. 2007.PubMed/NCBI
|
|
21
|
Darbar D, Hardy A, Haines JL and Roden DM:
Prolonged signal-averaged P-wave duration as an intermediate
phenotype for familial atrial fibrillation. J Am Coll Cardiol.
51:1083–1089. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Y, Xia M, Jin Q, Bendahhou S, Shi J,
Chen Y, Liang B, Lin J, Liu Y, Liu B, et al: Identification of a
KCNE2 gain-of-function mutation in patients with familial atrial
fibrillation. Am J Hum Genet. 75:899–905. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lundby A, Ravn LS, Svendsen JH, Hauns S,
Olesen SP and Schmitt N: KCNE3 mutation V17M identified in a
patient with lone atrial fibrillation. Cell Physiol Biochem.
21:47–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ravn LS, Aizawa Y, Pollevick GD,
Hofman-Bang J, Cordeiro JM, Dixen U, Jensen G, Wu Y, Burashnikov E,
Haunso S, et al: Gain of function in IKs secondary to a mutation in
KCNE5 associated with atrial fibrillation. Heart Rhythm. 5:427–435.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong K, Bjerregaard P, Gussak I and
Brugada R: Short QT syndrome and atrial fibrillation caused by
mutation in KCNH2. J Cardiovasc Electrophysiol. 16:394–396. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia M, Jin Q, Bendahhou S, He Y, Larroque
MM, Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, et al: A Kir2.1
gain-of-function mutation underlies familial atrial fibrillation.
Biochem Biophys Res Commun. 332:1012–1019. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Olson TM, Alekseev AE, Liu XK, Park S,
Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A and
Terzic A: Kv1.5 channelopathy due to KCNA5 loss-of-function
mutation causes human atrial fibrillation. Hum Mol Genet.
15:2185–2191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Li J, Lin X, Yang Y, Hong K, Wang
L, Liu J, Li L, Yan D, Liang D, et al: Novel KCNA5 loss-of-function
mutations responsible for atrial fibrillation. J Hum Genet.
54:277–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Olson TM, Michels VV, Ballew JD, Reyna SP,
Karst ML, Herron KJ, Horton SC, Rodeheffer RJ and Anderson JL:
Sodium channel mutations and susceptibility to heart failure and
atrial fibrillation. JAMA. 293:447–454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Watanabe H, Darbar D, Kaiser DW,
Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ and Roden
DM: Mutations in sodium channel beta1- and beta2-subunits
associated with atrial fibrillation. Circ Arrhythm Electrophysiol.
2:268–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang P, Yang Q, Wu X, Yang Y, Shi L, Wang
C, Wu G, Xia Y, Yang B, Zhang R, et al: Functional
dominant-negative mutation of sodium channel subunit gene SCN3B
associated with atrial fibrillation in a Chinese GeneID population.
Biochem Biophys Res Commun. 398:98–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hodgson-Zingman DM, Karst ML, Zingman LV,
Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett
JC Jr and Olson TM: Atrial natriuretic peptide frameshift mutation
in familial atrial fibrillation. N Engl J Med. 359:158–165. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren X, Xu C, Zhan C, Yang Y, Shi L, Wang
F, Wang C, Xia Y, Yang B, Wu G, et al: Identification of NPPA
variants associated with atrial fibrillation in a Chinese GeneID
population. Clin Chim Acta. 411:481–485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thibodeau IL, Xu J, Li Q, Liu G, Lam K,
Veinot JP, Birnie DH, Jones DL, Krahn AD, Lemery R, et al: Paradigm
of genetic mosaicism and lone atrial fibrillation: physiological
characterization of a connexin 43-deletion mutant identified from
atrial tissue. Circulation. 122:236–244. 2010. View Article : Google Scholar
|
|
35
|
Gollob MH, Jones DL, Krahn AD, Danis L,
Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, et al:
Somatic mutations in the connexin 40 gene (GJA5) in atrial
fibrillation. N Engl J Med. 354:2677–2688. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Jiang WF, Fang WY and Liu X: Connexin40 nonsense mutation in
familial atrial fibrillation. Int J Mol Med. 26:605–610.
2010.PubMed/NCBI
|
|
37
|
Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW,
Shi HF, Jiang WF and Fang WY: Novel connexin40 missense mutations
in patients with familial atrial fibrillation. Europace.
12:1421–1427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bruneau BG: The developmental genetics of
congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu DL, Chen FK, Liu YQ, Sheng YH, Yang R,
Kong XQ, Cao KJ, Gu HT and Qian LM: GATA-4 promotes the
differentiation of P19 cells into cardiac myocytes. Int J Mol Med.
26:365–372. 2010.PubMed/NCBI
|
|
41
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Xin YF, Liu XY, Liu ZM, Wang XZ
and Yang YQ: A novel NKX2-5 mutation in familial ventricular septal
defect. Int J Mol Med. 27:369–375. 2011.PubMed/NCBI
|
|
43
|
Liu XY, Wang J, Yang YQ, Zhang YY, Chen
XZ, Zhang W, Wang XZ, Zheng JH and Chen YH: Novel NKX2-5 mutations
in patients with familial atrial septal defects. Pediatr Cardiol.
32:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang J, Liu XY and Yang YQ: Novel NKX2-5
mutations responsible for congenital heart disease. Genet Mol Res.
10:2905–2915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gutierrez-Roelens I, De Roy L, Ovaert C,
Sluysmans T, Devriendt K, Brunner HG and Vikkula M: A novel
CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial
fibrillation and syncopes part of the phenotype? Eur J Hum Genet.
14:1313–1316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boldt LH, Posch MG, Perrot A, Polotzki M,
Rolf S, Parwani AS, Huemer M, Wutzler A, Ozcelik C and Haverkamp W:
Mutational analysis of the PITX2 and NKX2-5 genes in patients with
idiopathic atrial fibrillation. Int J Cardiol. 145:316–317. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, et al: GATA4 mutations cause
human congenital heart defects and reveal an interaction with TBX5.
Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang J, Fang M, Liu XY, Xin YF, Liu ZM,
Chen XZ, Wang XZ, Fang WY, Liu X and Yang YQ: A novel GATA4
mutation responsible for congenital ventricular septal defects. Int
J Mol Med. 28:557–564. 2011.PubMed/NCBI
|
|
49
|
Liu XY, Wang J, Zheng JH, Bai K, Liu ZM,
Wang XZ, Liu X, Fang WY and Yang YQ: Involvement of a novel
GATA4 mutation in atrial septal defects. Int J Mol Med.
28:17–23. 2011.
|
|
50
|
Yang YQ, Li L, Wang J, Liu XY, Chen XZ,
Zhang W, Wang XZ, Jiang JQ, Liu X and Fang WY: A novel GATA4
loss-of-function mutation associated with congenital ventricular
septal defect. Pediatr Cardiol. 33:539–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Posch MG, Boldt LH, Polotzki M, Richter S,
Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in
the cardiac transcription factor GATA4 in patients with lone atrial
fibrillation. Eur J Med Genet. 53:201–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang YQ, Wang MY, Zhang XL, Tan HW, Shi
HF, Jiang WF, Wang XH, Fang WY and Liu X: GATA4 loss-of-function
mutations in familial atrial fibrillation. Clin Chim Acta.
412:1825–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
54
|
Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao
H, Yan B, Liu Y, Yang Y and Chen YH: A novel GATA6 mutation in
patients with tetralogy of Fallot or atrial septal defect. J Hum
Genet. 55:662–667. 2010. View Article : Google Scholar
|
|
55
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with
congenital ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.
|
|
56
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang Y, Rath N, Hannenhalli S, Wang Z,
Cappola T, Kimura S, Atochina-Vasserman E, Lu MM, Beers MF and
Morrisey EE: GATA and Nkx factors synergistically regulate
tissue-specific gene expression and development in vivo.
Development. 134:189–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Nemer G, Qureshi ST, Malo D and Nemer M:
Functional analysis and chromosomal mapping of Gata5, a gene
encoding a zinc finger DNA-binding protein. Mamm Genome.
10:993–999. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Haïssaguerre M, Jaïs P, Shah DC, Takahashi
A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P and
Clémenty J: Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. N Engl J Med.
339:659–666. 1998.PubMed/NCBI
|
|
61
|
Mommersteeg MT, Brown NA, Prall OW, de
Gier-de Vries C, Harvey RP, Moorman AF and Christoffels VM: Pitx2c
and Nkx2-5 are required for the formation and identity of the
pulmonary myocardium. Circ Res. 101:902–909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mommersteeg MT, Christoffels VM, Anderson
RH and Moorman AF: Atrial fibrillation: a developmental point of
view. Heart Rhythm. 6:1818–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mommersteeg MT, Hoogaars WM, Prall OW, de
Gier-de Vries C, Wiese C, Clout DE, Papaioannou VE, Brown NA,
Harvey RP, Moorman AF and Christoffels VM: Molecular pathway for
the localized formation of the sinoatrial node. Circ Res.
100:354–362. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Watanabe Y, Benson DW, Yano S, Akagi T,
Yoshino M and Murray JC: Two novel frameshift mutations in NKX2.5
result in novel features including visceral inversus and sinus
venosus type ASD. J Med Genet. 39:807–811. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pabst S, Wollnik B, Rohmann E, Hintz Y,
Glänzer K, Vetter H, Nickenig G and Grohé C: A novel stop mutation
truncating critical regions of the cardiac transcription factor
NKX2-5 in a large family with autosomal-dominant inherited
congenital heart disease. Clin Res Cardiol. 97:39–42. 2008.
View Article : Google Scholar
|
|
66
|
Gruver EJ, Fatkin D, Dodds GA, Kisslo J,
Maron BJ, Seidman JG and Seidman CE: Familial hypertrophic
cardiomyopathy and atrial fibrillation caused by Arg663His
beta-cardiac myosin heavy chain mutation. Am J Cardiol. 83:H13–H18.
1999. View Article : Google Scholar : PubMed/NCBI
|
